BioPartnering North America--Spotlight on Canada.
The BioPartnering North America conference, held in Vancouver, included presentations covering drug pipeline developments from both large and small pharmaceutical companies. This conference report highlights selected presentations from drug developers from Canada. Investigational drugs discussed include davunetide (Allon Therapeutics Inc), ANG-1005 (Angiochem Inc), AQX-1125 (Aquinox Pharmaceuticals Inc), and Sertolin (Sernova Corp), APG-2305 (Allostera Pharma Inc). The DepoVax liposomal vaccine delivery platform from Immunovaccine Inc is also highlighted.
Croydon
Léonie
L
Freelance Scientific Consultant, Vancouver, BC, Canada. leoniecroydon@gmail.com
D000544:Alzheimer Disease / Q000188:drug therapy; D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use; D002170:Canada; D019496:Cancer Vaccines / Q000627:therapeutic use; D002626:Chemistry, Pharmaceutical; D004337:Drug Carriers; D004345:Drug Industry; D015507:Drugs, Investigational / Q000737:chemistry / Q000627:therapeutic use*; D006801:Humans; D007167:Immunotherapy / Q000379:methods; D047428:Protein Kinase Inhibitors / Q000627:therapeutic use; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D019496:Cancer Vaccines; D004337:Drug Carriers; D015507:Drugs, Investigational; D047428:Protein Kinase Inhibitors